This is to inform you that the shareholders of the Company at 33rd AGM of Garodia Chemicals Limited (''the Company'') which was held on Tuesday, September 30, 2025 at 04:00 P.M. (IST) through ....
Awaiting price reaction for this filing.
Garodia Chemicals held its 33rd AGM on September 30, 2025 via video conferencing, where shareholders approved six key resolutions. These include the appointment of M/s. S. V. Kulkarni and Associates as Secretarial Auditors for a 5-year term (FY 2025-26 to FY 2029-30), and the appointment of Mrs. Bhagyashri Nilesh Devrale as Non-Executive Non-Independent Director. Shareholders also approved the appointment of Mr. Ravindra Subhash Salunkhe as Managing Director, along with three new Independent Directors: Mr. Vikram Ravindra Sabnis (a Chartered Accountant with 18+ years of experience), Mr. Suraj Kodak (a medical doctor with an MD), and Mrs. Megha Brahmankar (with a background in Homeopathy and English Literature). All director appointments are for 5-year terms and none of the new appointees are related to existing directors.
The board has been largely reconstituted with a mix of Independent Directors and a new Managing Director, signalling a fresh leadership setup. For shareholders, this means new strategic direction going forward, though the appointments themselves are routine governance compliance items and unlikely to cause immediate stock price movement.